Cytokinetics Revenues Down $CYTK $XHS

Cytokinetics, Incorporated., has announced its financial results for the first quarter of FY-2015.

The results shows Revenues fall to $4.4 million from $ Million YoY, where as EPS (Net Loss) improves to -$0.23 from -$0.27 YoY.

View the full earnings release here.